These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30612340)

  • 41. Genetic Variation in the Catechol-O-Methyl Transferase Val108/158Met Is Linked to the Caudate and Posterior Cingulate Cortex Volume in Healthy Subjects: Voxel-Based Morphometry Analysis of Brain Magnetic Resonance Imaging.
    Watanabe K; Kakeda S; Yoshimura R; Ide S; Hayashi K; Katsuki A; Umene-Nakano W; Watanabe R; Abe O; Korogi Y
    PLoS One; 2015; 10(11):e0142862. PubMed ID: 26566126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The corticolimbic structural covariance network as an early predictive biosignature for cognitive impairment in Parkinson's disease.
    Chen YS; Chen HL; Lu CH; Lee CY; Chou KH; Chen MH; Yu CC; Lai YR; Chiang PL; Lin WC
    Sci Rep; 2021 Jan; 11(1):862. PubMed ID: 33441662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential optimal dopamine levels for set-shifting and working memory in Parkinson's disease.
    Fallon SJ; Smulders K; Esselink RA; van de Warrenburg BP; Bloem BR; Cools R
    Neuropsychologia; 2015 Oct; 77():42-51. PubMed ID: 26239947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic association of catechol-O-methyltransferase val(158)met polymorphism in Saudi schizophrenia patients.
    Al-Asmary S; Kadasah S; Arfin M; Tariq M; Al-Asmari A
    Genet Mol Res; 2014 Apr; 13(2):3079-88. PubMed ID: 24782165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's disease.
    Pereira JB; Aarsland D; Ginestet CE; Lebedev AV; Wahlund LO; Simmons A; Volpe G; Westman E
    Hum Brain Mapp; 2015 Aug; 36(8):2980-95. PubMed ID: 25950288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between catechol-O-methyltransferase genetic variation and functional connectivity in patients with first-episode schizophrenia.
    Wang H; Zhang B; Zeng B; Tang Y; Zhang T; Zhao S; Li C; Wang J; Goff DC
    Schizophr Res; 2018 Sep; 199():214-220. PubMed ID: 29730044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal brain volumetric changes and their predictive effects on cognition among cognitively asymptomatic patients with Parkinson's disease.
    Wen MC; Ng A; Chander RJ; Au WL; Tan LC; Kandiah N
    Parkinsonism Relat Disord; 2015 May; 21(5):483-8. PubMed ID: 25753847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Voxel-wise meta-analysis of structural changes in gray matter of Parkinson's disease patients with mild cognitive impairment.
    Qin B; Yang MX; Gao W; Zhang JD; Zhao LB; Qin HX; Chen H
    Braz J Med Biol Res; 2020; 53(6):e9275. PubMed ID: 32428131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele.
    Shahid M; Kim J; Leaver K; Hendershott T; Zhu D; Cholerton B; Henderson VW; Tian L; Poston KL
    Neurobiol Dis; 2019 Jul; 127():278-286. PubMed ID: 30826425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BDNF Val66Met polymorphism and cognitive impairment in Parkinson's disease-a meta-analysis.
    Yin Y; Su X; Pan L; Li C
    Neurol Sci; 2019 Sep; 40(9):1901-1907. PubMed ID: 31104169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of the COMT genotype in the underlying functional brain activity of context processing in schizophrenia and in relatives.
    Lopez-Garcia P; Cristobal-Huerta A; Young Espinoza L; Molero P; Ortuño Sanchez-Pedreño F; Hernández-Tamames JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():176-82. PubMed ID: 27421706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
    Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
    Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ;
    J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regional gray matter reductions associated with mild cognitive impairment in Parkinson's disease: A meta-analysis of voxel-based morphometry studies.
    Zheng D; Chen C; Song W; Yi Z; Zhao P; Zhong J; Dai Z; Shi H; Pan P
    Behav Brain Res; 2019 Oct; 371():111973. PubMed ID: 31128163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COMT Val 158 Met polymorphism is associated with nonverbal cognition following mild traumatic brain injury.
    Winkler EA; Yue JK; McAllister TW; Temkin NR; Oh SS; Burchard EG; Hu D; Ferguson AR; Lingsma HF; Burke JF; Sorani MD; Rosand J; Yuh EL; Barber J; Tarapore PE; Gardner RC; Sharma S; Satris GG; Eng C; Puccio AM; Wang KK; Mukherjee P; Valadka AB; Okonkwo DO; Diaz-Arrastia R; Manley GT;
    Neurogenetics; 2016 Jan; 17(1):31-41. PubMed ID: 26576546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-demented Parkinson's disease patients with apathy show decreased grey matter volume in key executive and reward-related nodes.
    Martinez-Horta S; Sampedro F; Pagonabarraga J; Fernandez-Bobadilla R; Marin-Lahoz J; Riba J; Kulisevsky J
    Brain Imaging Behav; 2017 Oct; 11(5):1334-1342. PubMed ID: 27730477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of COMT Genotype on Antero-posterior Cortical Functional Connectivity Underlying Interference Resolution.
    Jaspar M; Manard M; Dideberg V; Bours V; Maquet P; Collette F
    Cereb Cortex; 2016 Feb; 26(2):498-509. PubMed ID: 25205659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease.
    Mata IF; Johnson CO; Leverenz JB; Weintraub D; Trojanowski JQ; Van Deerlin VM; Ritz B; Rausch R; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson-Hiller AL; Espay AJ; Revilla FJ; Devoto J; Yearout D; Hu SC; Cholerton BA; Montine TJ; Edwards KL; Zabetian CP
    Neurobiol Aging; 2017 Aug; 56():211.e1-211.e7. PubMed ID: 28526295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between the catechol-O-methyltransferase (COMT) Val
    Nogueira NGHM; Bacelar MFB; Ferreira BP; Parma JO; Lage GM
    Brain Res Bull; 2019 Jan; 144():223-232. PubMed ID: 30445182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlations Between Methionine Cycle Metabolism, COMT Genotype, and Polyneuropathy in L-Dopa Treated Parkinson's Disease: A Preliminary Cross-Sectional Study.
    Andréasson M; Brodin L; Laffita-Mesa JM; Svenningsson P
    J Parkinsons Dis; 2017; 7(4):619-628. PubMed ID: 28759974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.